
Loading, please wait...

Loading, please wait...

The Telangana government has announced a comprehensive women health screening program to benefit approximately 46 lakh Self Help Group (SHG) members. Starting March 8, 2026, the state will provide 30 diagnostic tests to each participant. This massive public health drive coincides with International Women's Day. Health Minister C. Damodar Raja Narasimha confirmed that state-run Telangana Diagnostics will facilitate these medical evaluations.
The initiative operates under a 99-day special development plan beginning March 6. Consequently, the Health Department will implement screenings in three distinct phases over six months. Phase 1 focuses on improving health outcomes for mothers, infants, and adolescent girls. During this period, officials will also prioritize hospital cleanliness and conduct pediatric tests at Anganwadi centers.
Subsequently, from April 1 to 15, the government will organize extensive grassroots camps. These sessions aim to identify non-communicable diseases (NCDs) such as hypertension, diabetes, and various cancers. Afterward, the third phase will target tuberculosis elimination under the "TB Mukt Bharat" goal. Furthermore, the department plans to raise awareness regarding seasonal illnesses like dengue and malaria.
Beyond individual screenings, the government intends to enhance health infrastructure significantly. Specifically, 145 urban Primary Health Centres (PHCs) in the GHMC and Cyberabad regions will upgrade to polyclinics. This expansion ensures that specialty medical services become more accessible to urban populations. Therefore, this holistic approach addresses both preventive screening and long-term care delivery.
Q1: Who is eligible for the health screening program in Telangana?
The program specifically targets approximately 46 lakh women who are members of Self Help Groups (SHGs) across the state.
Q2: What types of medical tests are included in the screening?
Each participant will undergo 30 different diagnostic tests. These tests help identify non-communicable diseases like diabetes and hypertension, as well as infectious diseases like TB.
Q3: When will the health screening initiative officially launch?
The program is scheduled for a formal launch on International Women's Day, which falls on March 8, 2026.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Telangana launches a health profiling drive for 4.6 million women SHG members, featuring 30 diagnostic tests and phased screenings for NCDs, TB, and more....
7 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today